Prothrombin Complex Concentrates Market By Distribution Channel (Compound Pharmacies, Retail Pharmacies, And Hospital Pharmacies) & Region - Forecast 2018–2028
Prothrombin Complex Concentrates Market - Analysis, Outlook, Growth, Trends, Forecasts
- December 2018
- 223 pages
Prothrombin Complex Concentrates Market Overview
[223 Pages Report] The prothrombin complex concentrates market is valued at US$ 370 Mn in 2022. The market growth outlook seems modest with a CAGR of 3.5% during 2022-2028.
Estimated Market Size of Prothrombin Complex Concentrates Market in 2022
US$ 370 Mn
Projected Market Size of Prothrombin Complex Concentrates Market in 2028
US$ 455 Mn
CAGR during 2022-2028
During 2022-2028, manufacturers in the China and APEC regions are expected to see considerable advancements in the prothrombin complex concentrates market.
Companies like Shire, Octapharma AG, and CSL Behring GmbH currently control over 80% of the global market share.
In Europe, direct healthcare expenditures, including medical and hospital costs, for prothrombin complex concentrates are around US$ 400 thousand, whereas warfarin withdrawal treatment costs over US$ 1.2 Mn.
Prothrombin Complex Concentrates Market Witnessing Considerable Growth in China
According to the discussions held with key opinion leaders in the prothrombin complex concentrates market, a substantial growth has been witnessed in the China market for prothrombin complex concentrates. Manufacturers operating in the China & APEC markets are estimated to have significant growth opportunities in the prothrombin complex concentrates market over the forecast period.
Unmet Hemophilia Therapeutic Needs and Growing Geriatric Population
As the requirement of anticoagulation therapy with oral anticoagulants is increasing amongst the geriatric population, the need to reverse anticoagulation in adverse condition is also increasing. Thus, the growing geriatric population is expected to fuel the growth of the prothrombin complex market over the forecast period. The worldwide incidence of hemophilia is not well known, however, it has been estimated that more than 400,000 people have hemophilia. Approximately 75% of people with hemophilia have been estimated to receive inadequate treatment or have no access to treatment.
Market Research Methodology - Perfected through Years of Diligence
A key factor for our unrivaled market research accuracy is our expert- and data-driven research methodologies. We combine an eclectic mix of experience, analytics, machine learning, and data science to develop research methodologies that result in a multi-dimensional, yet realistic analysis of a market.
80% Revenue Contribution by Leading Manufacturers in Prothrombin Complex Concentrates Market
The prothrombin complex concentrates market is mainly dominated by the global manufactures. The manufacturers of prothrombin complex concentrates are competing based on adoption of prothrombin complex concentrates. The growing demand for optimized & sustainable healthcare has create immense growth opportunities for the global manufacturers.
Companies such as Shire, Octapharma AG, and CSL Behring GmbH hold approximately 80% revenue share in the global prothrombin complex concentrates market. Also, companies operating in the prothrombin complex concentrates market are collaborating with retailers and local distributors to increase the penetration of prothrombin complex concentrates.
The company’s report titled “Prothrombin Complex Concentrates Market” provides detailed information about the growth parameters of the companies operating in the prothrombin complex concentrates market. It includes detailed assessment of the competitive environment in the prothrombin complex concentrates market.
The market study provides comprehensive data on each stakeholder in the prothrombin complex concentrates market, including Shire, Octapharma AG, Nihon Pharmaceutical Co Ltd, Sanquin Blood Supply Foundation, CSL Behring GmbH, Kedrion Biopharma Inc, and Grifols, S.A. The report provides readers with all-encompassing data on each prothrombin complex concentrates manufacturer’s revenue shares, winning strategies, and latest information on key strategies in the prothrombin complex concentrates market.
Prothrombin concentrates also known as prothrombin complex concentrates (PCC) are medications containing various clotting factors. PCCs are used for treating patients with hemophilia B, and used in those with not enough of these factors due to other reasons such as warfarin therapy.
3-Factor prothrombin complex concentrates are prothrombin concentrates containing factors II, IX, and X. For instance, Uman Complex DI (Grifols Biologicals Inc.). 4-Factor Prothrombin complex concentrates are prothrombin concentrates containing factors II, VII, IX, and X. For instance, Kcentra/Confidex/Beriplex (CSL Behring GmbH).
About the Report
The study on the prothrombin complex concentrates market was recently published by the company, which provides comprehensive information about the most important market dynamics that prove instrumental in the growth of the prothrombin complex concentrates market during 2018-2026.
Companies in the prothrombin complex concentrates market can find the most accurate quantitative and qualitative information about the growth parameters of the other prothrombin complex concentrates manufacturers, which can help them develop business strategies in the coming future.
Additional Questions Answered
Readers can find detailed information about the important positive and negative factors affecting the prothrombin complex concentrates market during the forecast period. Additionally, the report also contains valuable information that can provide prothrombin complex concentrates manufacturers with answers to critical questions, such as
- Which types of products account for the maximum demand for prothrombin complex concentrates market? Why is it so?
- Why is the sale of prothrombin complex concentrates high in North America? What are the factors customers seek in prothrombin complex concentrates?
- Which factors are influencing the strategies of players in the prothrombin complex concentrates market?
- What are the current trends adopted by various companies?
- What are the strategies being applied by the manufacturers in order to sustain themselves in the competitive market?
The process of market research followed by the company commences with extensive secondary research of the prothrombin complex concentrates market. We have obtained industry-validated, historic, and current data about the demand for prothrombin complex concentrates across the globe. Comprehensive secondary research was followed by extensive and in-depth primary research, where detailed information about the prothrombin complex concentrates market was obtained in terms of value (US$ Million).
Based on thorough secondary and primary research of the growth parameters of the prothrombin complex concentrates market, we have come up with the most precise forecast on how the prothrombin complex concentrates market will grow during the forecast period.
The report on the prothrombin complex concentrates market provides salient information on market players. The prothrombin complex concentrates market is segmented by region, product type, indication, and distribution channel, to analyze segment-wise growth of the prothrombin complex concentrates market.
Based on regions, the prothrombin complex concentrates market is segmented into seven regions – North America, Latin America, Western Europe, Eastern Europe, Asia Pacific Excluding China & Japan (APECJ), Japan, China, and the Middle East & Africa (MEA). The prothrombin complex concentrates market by product type is segmented into 3-Factor prothrombin complex concentrates, and 4-factor prothrombin complex concentrates.
By indication, the prothrombin complex concentrates market is segregated into hemorrhagic episodes in factor IX defficiency - Haemiohilia B, trauma, life-threatening coagulopathy with acute bleeding, warfarin-associated acute, life threatening bleeding, and non-warfarin anticoagulant reversal with acute bleeding. By distribution channel, the prothrombin complex concentrates market is segregated into compound pharmacies, retail pharmacies, and hospital pharmacies.